New Jersey-based Bristol-Myers Squibb Company (BMY) is a global biopharmaceutical giant focused on discovering, developing and delivering innovative medicines for serious diseases, with core areas including oncology, immunology, cardiovascular conditions and blood disorders. Bristol-Myers Squibb commands a powerful presence in oncology, led by blockbuster immuno-oncology therapies including Opdivo, Opdivo Qvantig, and Yervoy, among others. With a market capitalization of around $100.3 billion, Bristol-Mye ...